A change in the apparent diffusion coefficient after treatment with bevacizumab is associated with decreased survival in patients with recurrent glioblastoma multiforme

Author： PALDINO M J   DESJARDINS A   FRIEDMAN H S   VREDENBURGH J J   BARBORIAK D P  

Publisher： British Institute of Radiology

ISSN： 0007-1285

Source： British Journal of Radiology, Vol.85, Iss.1012, 2012-04, pp. : 382-389

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series

By  

Case Reports in Neurology, Vol. 8, Iss. 1, 2016-01 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

Resolution of Cystic Enhancement to Add-On Tumor Treating Electric Fields for Recurrent Glioblastoma after Incomplete Response to Bevacizumab

By  

Case Reports in Neurology, Vol. 6, Iss. 1, 2014-04 ,pp. : 109-115

Karger

Access to resources Recommend Favorite

Glioblastoma multiforme with atypical diffusion-weighted MR findings

By Hakyemez B   Erdogan C   Yildirim N   Parlak M  

British Journal of Radiology, Vol. 78, Iss. 935, 2005-11 ,pp. : 989-992

British Institute of Radiology

Access to resources Recommend Favorite

Elderly Patients with Glioblastoma Multiforme – An Underestimated Subpopulation?

By  

Neuroepidemiology, Vol. 33, Iss. 1, 2009-03 ,pp. : 23-24

Karger

Access to resources Recommend Favorite

Infarct Volume on Apparent Diffusion Coefficient Maps Correlates with Length of Stay and Outcome after Middle Cerebral Artery Stroke

By  

Cerebrovascular Diseases, Vol. 15, Iss. 3, 2003-03 ,pp. : 188-191

Karger

Access to resources Recommend Favorite